Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2026
  • Dowloads 129

Original Research

Open Access

Chylous ascites after lymphadenectomy for gynecologic malignancies: the conservative treatment

  • Yong-Soon Kwon11
  • Jae Young Kwack1
  • Kyong Shil Im2,*,
  • Eunhye Park2

1Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Ulsan University Hospital, Ulsan

2Department of Anesthesiology and Pain Medicine, Uijeongbu St Mary’s Hospital, College of Medicine, Catholic University of Korea, Seoul (Korea)

DOI: 10.12892/ejgo3877.2018 Vol.39,Issue 2,April 2018 pp.253-256

Published: 10 April 2018

*Corresponding Author(s): Kyong Shil Im E-mail: idonga@catholic.ac.kr

PDF (238.91 kB) View Full-text

Abstract

Purpose: This study aimed to evaluate the efficacy and outcomes of the conservative treatment for postoperative chylous ascites in patients with gynecologic malignancies. Materials and Methods: The authors retrospectively analyzed 107 patients who underwent pelvic and/or para-aortic lymphadenectomy (PLND and/or PALND) for gynecologic malignancies. Results: Among the 107 cases, chylous ascites occurred in 13/81 of patients who received PLND and PALND, in 2/3 patients who received only PALND, and none of the patients who received only PLND. The mean time interval between the operation and the appearance of chylous ascites was 2.8 (range, 2–5) days. The cure rate of chylous ascites with the conservative therapy was 100%. None of the cases had recurrent chylous ascites during follow-up. Conclusions: The conservative therapeutic strategy for treating chylous ascites can be a front option in patients with chylous ascites and a gynecologic malignancy without invasive interventions.

Keywords

Chylous ascites; Gynecologic malignancies; Conservative treatment.

Cite and Share

Yong-Soon Kwon1,Jae Young Kwack,Kyong Shil Im,Eunhye Park. Chylous ascites after lymphadenectomy for gynecologic malignancies: the conservative treatment. European Journal of Gynaecological Oncology. 2018. 39(2);253-256.

URL:

https://www.ejgo.net/articles/10.12892/ejgo3877.2018

References

[1] Staats B.A., Ellefson R.D., Budahn L.L., Dines D.E., Prakash U.B., Offord K.: “The lipoprotein profile of chylous and nonchylous pleural effusions”. Mayo. Clin. Proc., 1980, 55, 700.

[2] Frey M.K., Ward N.M., Caputo T.A., Taylor J., Worley Jr M.J., Slomovitz B.M.: “Lymphatic ascites following pelvic and paraaortic lymphadenectomy procedures for gynecologic malignancies”. Gynecol. Oncol., 2012, 125, 48.

[3] Combe J., Buniet J.M., Douge C., Bernard Y., Camelot G.: “Chylothorax and chylous ascites following surgery of an inflammatory aortic aneurysm. Case report with review of the literature”. J. Mal. Vasc., 1992, 17, 151.

[4] Baniel J., Foster R.S., Rowland R.G., Bihrle R., Donohue J.P.: “Complications of post-chemotherapy retroperitoneal lymph node dissection”. J. Urol., 1995, 153, 976.

[5] Evans J.G., Spiess P.E., Kamat A.M., Wood C.G., Hernandez M., Pettaway C.A., et al.: “Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M.D Anderson experience”. J. Urol., 2006, 176, 1463.

[6] Han D., Wu X., Li J., Ke G.: “Postoperative chylous ascites in patients with gynecologic malignancies”. Int. J. Gynecol. Cancer, 2012, 22, 186.

[7] Tulunay G., Ureyen I., Turan T., Karalok A., Kavak D., Ozgul N., et al.: “Chylous ascites: analysis of 24 patients”. Gynecol. Oncol., 2012, 127, 191.

[8] Aalami O.O., Allen D.B., Organ Jr C.H.: “Chylous ascites: a collective review”. Surgery, 2000, 128, 761.

[9] Kaas R., Rustman L.D., Zoetmulder F.A.: “Chylous ascites after oncological abdominal surgery: incidence and treatment”. Eur. J. Surg. Oncol., 2001, 27, 187.

Submission Turnaround Time

Top